Pharmacological Treatment of Acute Vulvovaginal Candidiasis

Berg AO Heidrich FE Fihn SD Establishing the cause of symptoms in women in a family practice. JAMA 1984;251:620–5.

Hurley R DeLouvois J. Candida vaginitis. Postgrad Med J 1979;55:645–7.

Fleury FJ. Adult vaginitis. Clin Obstet Gynecol 1981;24:407–38.

Oriel JD Partridge BM Denny MJ Coleman JC. Genital yeast infection. BMJ 1972;4:761–4.

Morton RS Rashid S. Candidal vaginitis: Natural history, predisposing factors and prevention. Proc R Soc Med 1977;70(suppl 4):3–10.

Bland PB. Experimental vaginal and cutaneous moniliasis. Clinical and laboratory studies of certain monilias associated with vaginal, oral and cutaneous thrush. Arch Dermatol Syphilol 1937;36:760–7.

McCourtie J Douglas LG. Relationship between cell surface composition of Candida albicans and adherence to acrylic after-growths on different carbon sources. Infect Immun 1981;32:1234–41.

Caruso LJ. Vaginal moniliasis after tetracycline therapy: The effects of amphoteracin B. Am J Obstet Gynecol 1964;90:374–8.

Oriel JD Waterworth PM. Effect of minocycline and tetracycline on the vaginal yeast flora. J Clin Pathol 1975;28:403–6.

Sobel JD Myers PG Kaye D Levison ME. Candida albicans adherence to vaginal and buccal epithelial cells. J Infect Dis 1981;143:76–82.

Narayanan TK Rao GR. Beta-indole-ethanol and beta-indole lactic acid production by Candida species: Their antibacterial and autoantibiotic action. Antimicrob Agents Chemother 1976;9:375–80.

Warnock D Speller DC Milne JD Hilton AC Kershaw PI. Epidemiological investigations of patients with vulvovaginal candidosis: Application of a resistogram method for strain differentiation of Candida albicans . Br J Vener Dis 1979;55:357–61.

Odds FC. Genital candidosis. Clin Exp Dermatol 1982;7:345–54.

Horwitz BJ Edelstein SW Lippman L. Candida tropicalis vulvovaginitis. Obstet Gynecol 1985;66:229–32.

Odds FC Abbott AB Stiller RL Scholer HJ Polak A Stevens DA. Analysis of Candida albicans phenotype from different geographical and anatomical sources. J Clin Microbiol 1983;18:849–57.

O'Connor BH Adler MW. Current approaches to the diagnosis, treatment and reporting of trichomoniasis and candidosis. Br J Vener Dis 1979;55:52–7.

Odds FC. Cure and relapse with antifungal therapy. Proc R Soc Med 1977;70:24–32.

Lang WE. Nystatin vaginal tablets in the treatment of candidal vulvovaginitis. Obstet Gynecol 1956;8:364–9.

Bingham JS Steele CE. Treatment of vaginal candidosis with econazole nitrate and nystatin. Br J Vener Dis 1981;57:204–7.

Balmer JA. Three-day therapy of vulvovaginal candidiasis with econazole — a multicentric study comprising 996 cases. Am J Obstet Gynecol 1976;126:436–41.

Masterton G Napier IR Henderson JN Roberts JE. Three-day clotrimazole treatment in candidal vulvovaginitis. Br J Vener Dis 1977;53:126–8.

Masterton G Henderson J Napier IR Moffet M. Six-day clotrimazole therapy in vaginal candidiasis. Curr Med Res Opin 1975;3:83–8.

Milsom I Forssman L. A double-blind trial of 4-day and 6-day therapy with clotrimazole in vaginal candidiasis. Pharmatherapeutica 1978;2:8–11.

Sobel JD Schmitt PA Meriwether C. Clotrimazole treatment of Candida vulvovaginitis. Obstet Gynecol 1989;73:330–4.

Milsom I Forssman L. Treatment of vaginal candidosis with a single 500 mg clotrimazole pessary. Br J Vener Dis 1982;58:124–6.

Iwata K Yamaguchi H Hiratani T. Mode of action of clotrimazole. Sabouraudia 1973;11:158–66.

Holt RJ. Recent development in antimycotic chemotherapy. Infection 1974;2:95–107.

Odds FC MacDonald F. Persistence of miconazole in vaginal secretions after single application. Br J Vener Dis 1981;57:400–1.

Bergstein NAM. Treatment of vulvovaginal candidal infection with miconazole-coated tampons. Br J Vener Dis 1980;56:408–11.

Tooley PJH. Patient and doctor preferences in the treatment of vaginal candidiasis. Practitioner 1985;229:655–60.

Bisschop MPJM Merkus JMWM Scheygrond H van Cutsem J. Patient's preference of oral treatment in vaginal candidosis. J Drug Ther Res 1985;10:587–9.

Bisschop MPJM Merkus JMWM Scheygrond H van de Kuy A. Treatment of vaginal candidosis with ketoconazole, a new orally active antimycotic. Eur J Obstet Gynaecol Reprod Biol 1979;9:253–8.

Cauwenbergh G. Ketoconazole, international experience in vaginal candidosis: A review. In: Elliot BW , ed. Oral therapy in vaginal candidosis. Proceedings of a symposium held in Oxford. Symposium series number 13. Oxford: The Medicine Publishing Foundation 1984:33.

Pont A Williams PL Loose DS Ketoconazole blocks adrenal steroid synthesis. Ann Intern Med 1982;97:370–2.

Janssen PAJ Symeons JE. Hepatic reactions during ketoconazole treatment. Am J Med 1983;74:80–85.

Dellenback P. Penetration of fluconazole into vaginal tissues and secretions. In: Richardson G , ed. Fluconazole and its role in vaginal candidiasis. ICSS No. 160. London: Royal Society of Medicine 1989:19.

Houang ET Chappatte O Macree PV Thorpe JE. Fluconazole levels in plasma and vaginal secretions of patients after a 150 mg single oral dose and role in eradication of infection in vaginal candidiasis. Antimicrob Agents Chemother 1990;34:909–10.

Brammer KW. Treatment of vaginal candidiasis with a single oral dose of fluconazole. Eur J Clin Microbiol Infect Dis 1988;17:364–7.

Stein GE Christensen S Mummaw N. Comparative study of fluconazole and clotrimazole in the treatment of vulvovaginal candidiasis. Ann Pharmacother 1991;25:582–5.

Rees T Phillips R. Multicentre comparison of one-day oral therapy with fluconazole or itraconazole in vaginal candidiasis. Int J Gynaecol Obstet 1992;37:33–8.

International Multicentre Trial. A comparison of single dose oral fluconazole with 3-day intravaginal clotrimazole in the treatment of vaginal candidiasis. Br J Obstet Gynaecol 1989;96:226–32.

Phillips RJM Watson SA McKay FF. An open multicentre study of the efficacy and safety of a single dose of fluconazole 150 mg in the treatment of vaginal candidiasis in general practice. Br J Clin Pract 1990;44:219–22.

Kutzer E Oittner R Leadolter S Brammer KW. A comparison of fluconazole and ketoconazole in the oral treatment of vaginal candidiasis: Report of a double-blind multicentre study. Eur J Obstet Gynaecol Reprod Biol 1988;29:305–13.

Cauwenbergh G. Itraconazole: The first orally active antifungal for single day treatment of vaginal candidosis. Curr Ther Research 1987;41:210–14.

Larosa E Cauwenbergh G Cilli P Itraconazole pharmacokinetics in the female genital tract: Plasma and tissue levels in patients undergoing hysterectomy after a single dose of 200 mg itraconazole. Eur J Obstet Gynaecol Reprod Biol 1986;23:85–9.

Tobin JM Loo P Granger SE. Treatment of vaginal candidiasis: A comparative study of the efficacy and acceptability of itraconazole and clotrimazole. Genitourin Med 1992;68:36–8.

Wesel S. Itraconazole: A single dose oral treatment for acute vulvovaginal candidiasis. Br J Clin Pract Symp Suppl 1990;71:77–80.

Silva-Cruz A Andrade L Sobral L Francisca A. Itraconazole versus placebo in the management of vaginal candidiasis. Int J Gynaecol Obstet 1991;36:229–32.

Sanz FS Hermanz AP. Randomised comparative trial of three regimens of itraconazole for treatment of vaginal mycoses. Rev Infect Dis 1987;9:139–42.

Van der Pas H. Clinical experience with itraconazole in the treatment of vaginal candidosis. Int J Exper Clin Chemother 1989;2:43–6.

Stein GE Mummaw N. Placebo-controlled trial of itraconazole for treatment of acute vaginal candidiasis. Antimicrob Agents Chemother 1993;37:89–92.

Peeters F Van der Pas H Proost J Itraconazole (R51211), a new orally active triazole derivative for treatment of vaginal candidosis. Curr Ther Res 1986;39:496–504.

Redondo-Lopez V Lynch M Schmitt C Cook R Sobel JD. Torulopis glabrata vaginitis: Clinical aspects and susceptibility to antifungal agents. Obstet Gynecol 1990;76:651–5.

Merkus JMWM. Treatment of vaginal candidosis — orally or vaginally? J. Am Acad Dermatol 1990;23:568–72.